Glycosylated gold nanoparticles in point of care diagnostics: from aggregation to lateral flow

George W. Hawker-Bond, Panagiotis G. Georgiou, Simone Dedola, Robert A. Field

Research output: Contribution to journalReview articlepeer-review

Abstract

Current point-of-care lateral flow immunoassays, such as the home pregnancy test, rely on proteins as detection units (e.g. antibodies) to sense for analytes. Glycans play a fundamental role in biological signalling and recognition events such as pathogen adhesion and hence they are promising future alternatives to antibody-based biosensing and diagnostics. Here we introduce the potential of glycans coupled to gold nanoparticles as recognition agents for lateral flow diagnostics. We first introduce the concept of lateral flow, including a case study of lateral flow use in the field compared to other diagnostic tools. We then introduce glycosylated materials, the affinity gains achieved by the cluster glycoside effect and the current use of these in aggregation based assays. Finally, the potential role of glycans in lateral flow are explained, and examples of their successful use given.

Original languageEnglish
Pages (from-to)7238-7259
Number of pages22
JournalChemical Society Reviews
Volume51
Issue number16
DOIs
Publication statusPublished - 27 Jul 2022

Fingerprint

Dive into the research topics of 'Glycosylated gold nanoparticles in point of care diagnostics: from aggregation to lateral flow'. Together they form a unique fingerprint.

Cite this